Literature DB >> 12644238

Isolation and characterisation of a novel bacteriocin produced by Bacillus thuringiensis strain B439.

Melissa Ahern1, Saskia Verschueren, Douwe van Sinderen.   

Abstract

Bacillus thuringiensis strain B439 produces a bacteriocin-like inhibitory substance in its growth medium. This antimicrobial peptide, referred to as thuricin 439, acts as a bacteriocidal peptide and exhibits an apparent narrow range of inhibitory activity, essentially only affecting growth of Bacillus cereus and B. thuringiensis strains. It remains active over a relatively wide pH and temperature range, showing no loss of activity following heat treatments up to 80 degrees C. Purification of thuricin 439 was achieved using several chromatographic steps, which resulted in the identification of two peptides with inhibitory activity. These two peptides were shown to possess identical N-terminal sequences, but different molecular masses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12644238     DOI: 10.1016/S0378-1097(03)00086-7

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  14 in total

1.  Purification and characterization of two novel antimicrobial peptides Subpeptin JM4-A and Subpeptin JM4-B produced by Bacillus subtilis JM4.

Authors:  Shimei Wu; Shifang Jia; Dandan Sun; Meiling Chen; Xiuzhu Chen; Jin Zhong; Liandong Huan
Journal:  Curr Microbiol       Date:  2005-10-05       Impact factor: 2.188

2.  Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile.

Authors:  Mary C Rea; Clarissa S Sit; Evelyn Clayton; Paula M O'Connor; Randy M Whittal; Jing Zheng; John C Vederas; R Paul Ross; Colin Hill
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-30       Impact factor: 11.205

3.  Sonorensin: an antimicrobial peptide, belonging to the heterocycloanthracin subfamily of bacteriocins, from a new marine isolate, Bacillus sonorensis MT93.

Authors:  Lipsy Chopra; Gurdeep Singh; Vikas Choudhary; Debendra K Sahoo
Journal:  Appl Environ Microbiol       Date:  2014-03-07       Impact factor: 4.792

Review 4.  Cysteine-rich low molecular weight antimicrobial peptides from Brevibacillus and related genera for biotechnological applications.

Authors:  Piyush Baindara; Anoop Kapoor; Suresh Korpole; Vishakha Grover
Journal:  World J Microbiol Biotechnol       Date:  2017-05-22       Impact factor: 3.312

5.  Anti-listerial Bactericidal Activity of Lactobacillus plantarum DM5 Isolated from Fermented Beverage Marcha.

Authors:  Deeplina Das; Arun Goyal
Journal:  Probiotics Antimicrob Proteins       Date:  2013-09       Impact factor: 4.609

6.  Characterization of a new bacteriocin-like inhibitory peptide produced by Lactobacillus sakei B-RKM 0559.

Authors:  Gulyaim K Abitayeva; Maira S Urazova; Arman S Abilkhadirov; Zinigul S Sarmurzina; Serik M Shaikhin
Journal:  Biotechnol Lett       Date:  2021-10-15       Impact factor: 2.461

7.  Identification, purification and characterization of laterosporulin, a novel bacteriocin produced by Brevibacillus sp. strain GI-9.

Authors:  Pradip Kumar Singh; Vikas Sharma; Prabhu B Patil; Suresh Korpole
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

8.  Characterization of Bacteriocin like inhibitory substance produced by a new Strain Brevibacillus borstelensis AG1 Isolated from 'Marcha'.

Authors:  Nivedita Sharma; Anupama Gupta; Neha Gautam
Journal:  Braz J Microbiol       Date:  2014-10-09       Impact factor: 2.476

Review 9.  Dissecting the Environmental Consequences of Bacillus thuringiensis Application for Natural Ecosystems.

Authors:  Maria E Belousova; Yury V Malovichko; Anton E Shikov; Anton A Nizhnikov; Kirill S Antonets
Journal:  Toxins (Basel)       Date:  2021-05-16       Impact factor: 4.546

10.  Bacteriocins synthesized by Bacillus thuringiensis: generalities and potential applications.

Authors:  Elma Laura Salazar-Marroquín; Luis J Galán-Wong; Víctor Ricardo Moreno-Medina; Miguel Ángel Reyes-López; Benito Pereyra-Alférez
Journal:  Rev Med Microbiol       Date:  2016-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.